CRO launches tech group for data capture solution

Contract researcher Cmed Group has begun marketing its Timaeus data capture and management solution for clinical trials. The UK-based CRO has launched a collaborative arm, Cmed Technology, to sell Timaeus and partner with systems integrators and consultancies for its use.

Timaeus development, at the hands of a CRO, has yielded a "fundamentally different" solution, says Cmed Group CEO David Connelly, in an announcement. It combines distributed computing, virtualization, Internet, appliance and mobile technologies into one platform. Role-based workflow helps investigators manage data end-to-end, without reconciliation. The offering is available in software-as-a-service and enterprise models.

Another recent case of CRO/tech-offshoot collaboration is the Phase III data capture solution launched by Parexel and Perceptive Informatics last month. The Internet-based platform from Perceptive targets Phase IIIb and IV clinical trials, registries, risk management programs and post-approval safety surveillance, as reported. Such data are increasingly sought by regulators. Parexel contributes trial expertise from its Peri Approval Clinical Excellence team

- here's the Timaeus release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.